PATIENT PREFERENCES, TRADE-OFFS AND ACCEPTABLE RISKS IN THE TREATMENT OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A STEP TOWARDS SHARED DECISION-MAKING
Bruni C, Heidenreich S, Duenas A, Hoffmann-Vold AM, Gabrielli A, Allanore Y, Chatelus E, Distler J, Hachulla E, Hsu V, Hunzelmann N, Khanna D, Truchetet ME, Walker U, Alves M, Schoof N, Saketkoo LA, Distler O (2021)
Publication Type: Conference contribution
Publication year: 2021
Journal
Publisher: BMJ PUBLISHING GROUP
City/Town: LONDON
Pages Range: 681-682
Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES
DOI: 10.1136/annrheumdis-2021-eular.2112
Authors with CRIS profile
Involved external institutions
Boehringer Ingelheim Pharma GmbH & Co. KG
Germany (DE)
Centre Hospitalier Universitaire de Bordeaux / CHU Bordeaux
France (FR)
The State University of New Jersey (Rutgers)
United States (USA) (US)
Universität zu Köln
Germany (DE)
Universitätsspital Zürich (USZ)
Switzerland (CH)
Università degli Studi di Firenze / University of Florence
Italy (IT)
Evidera
United States (USA) (US)
Tulane University
United States (USA) (US)
LILLE 1 University - Science and Technology
France (FR)
Universitätsspital Basel
Switzerland (CH)
Hôpitaux universitaires de Strasbourg (HUS) / University Hospital Strasbourg
France (FR)
University of Paris 5 - René Descartes / Université Paris V René Descartes
France (FR)
Oslo University Hospital / Oslo Universitetssykehus Rikshospitalet
Norway (NO)
University of Michigan
United States (USA) (US)
Università Politecnica delle Marche (UNIVPM) / Marche Polytechnic University
Italy (IT)
Germany (DE)
Centre Hospitalier Universitaire de Bordeaux / CHU Bordeaux
France (FR)
The State University of New Jersey (Rutgers)
United States (USA) (US)
Universität zu Köln
Germany (DE)
Universitätsspital Zürich (USZ)
Switzerland (CH)
Università degli Studi di Firenze / University of Florence
Italy (IT)
Evidera
United States (USA) (US)
Tulane University
United States (USA) (US)
LILLE 1 University - Science and Technology
France (FR)
Universitätsspital Basel
Switzerland (CH)
Hôpitaux universitaires de Strasbourg (HUS) / University Hospital Strasbourg
France (FR)
University of Paris 5 - René Descartes / Université Paris V René Descartes
France (FR)
Oslo University Hospital / Oslo Universitetssykehus Rikshospitalet
Norway (NO)
University of Michigan
United States (USA) (US)
Università Politecnica delle Marche (UNIVPM) / Marche Polytechnic University
Italy (IT)
How to cite
APA:
Bruni, C., Heidenreich, S., Duenas, A., Hoffmann-Vold, A.M., Gabrielli, A., Allanore, Y.,... Distler, O. (2021). PATIENT PREFERENCES, TRADE-OFFS AND ACCEPTABLE RISKS IN THE TREATMENT OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A STEP TOWARDS SHARED DECISION-MAKING. In ANNALS OF THE RHEUMATIC DISEASES (pp. 681-682). LONDON: BMJ PUBLISHING GROUP.
MLA:
Bruni, C., et al. "PATIENT PREFERENCES, TRADE-OFFS AND ACCEPTABLE RISKS IN THE TREATMENT OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A STEP TOWARDS SHARED DECISION-MAKING." Proceedings of the ANNALS OF THE RHEUMATIC DISEASES LONDON: BMJ PUBLISHING GROUP, 2021. 681-682.
BibTeX: Download